Insight Molecular Diagnostics Inc. (IMDX) Live Share Price, Invest From India

Insight Molecular Diagnostics Inc. Stock Performance

as on May 14, 2026 at 2:15 pm IST

Day's Low
Day's High
$4.93
Day's Price Range
$5.39
$5.10
3.33%
Downside
5.69%
Upside
52 Week's Low
52 Week's High
$2.33
52-Week Price Range
$8.51
$5.10
54.31%
Downside
66.86%
Upside

Insight Molecular Diagnostics Inc. share price movements today

Previous Close: $4.98
Open: $5.00
Volume: 583.4K
Day's Low - High: $4.93 - $5.39
52 Week Low - High: $2.33 - $8.51

Insight Molecular Diagnostics Inc. Historical Returns

1 Month Return: + 37.95 %
3 Month Return: -10.59 %
1 Year Return: 0 %
3 Year Return: 0 %
5 Year Return: 0 %

Insight Molecular Diagnostics Inc. Stock Fundamentals & Key Indicators

Check Insight Molecular Diagnostics Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$158.5M

EPS (TTM)

-0.745

Dividend Yield

0.00%

PE Ratio (TTM)

PEG Ratio

Return On Equity TTM

-23603.11%

Insight Molecular Diagnostics Inc. vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Insight Molecular Diagnostics Inc. with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %
Insight Molecular Diagnostics Inc.	NA	$158.5M	NA	NA	0.00%
Waters Corporation	HOLD	$34.2B	12.8%	44.34	11.93%
IDEXX Laboratories Inc	BUY	$42.0B	0.73%	39.2	24.63%
Thermo Fisher Scientific Inc	BUY	$168.2B	0.05%	24.88	15.15%
Danaher Corporation	BUY	$117.9B	-34.43%	32.33	14.89%

Indian Investors' Interest in Insight Molecular Diagnostics Inc. Stock

Search interest for Insight Molecular Diagnostics Inc. Stock has increased by 410% in the last 30 days, reflecting an upward trend in search activity.

Time period: April 14, 2026 to May 14, 2026

Change:410% versus previous 30 day period

Insight Molecular Diagnostics Inc. Quarterly Profit & Loss

All numbers in Millions USD

	Jun 2023	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Total Revenue	0	0	0	0	0	1	2	0	0	1
Gross Profit	0	0	0	0	0	0	1	0	0	-1
Operating Income	-8	-6	-9	-4	-13	-33	-6	-9	-11	-2
EBITDA	-7	-6	-8	-4	-13	-32	-6	-9	-10	-2
Interest Expense	0	0	0	0	0	0	0	0	0	0
Depreciation	-	-	0	0	0	0	0	0	0	0
Income Before Tax	-8	-6	-9	-4	-13	-33	-6	-9	-10	-22
Income Tax Expense	4	0	8	-	-	-	-	-	-	-
Net Income	-8	-6	-9	-4	-13	-33	-6	-9	-10	-22
Net Profit Margin	-1799.78%	-1512.59%	-5186.93%	-4355.77%	-11733.04%	-2255.11%	-312.02%	-1880.69%	-4174.62%	-2015.36%

Insight Molecular Diagnostics Inc. Annual Profit & Loss

All numbers in Millions USD

	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Total Revenue	1	2	0	1	1	4
Gross Profit	0	1	0	0	0	0
Operating Income	-29	-53	-17	-25	-61	-30
EBITDA	-30	-48	-13	-23	-59	-28
Interest Expense	0	0	0	0	0	0
Depreciation	-	4	5	1	1	2
Income Before Tax	-31	-52	-18	-24	-60	-50
Income Tax Expense	-1	-9	54	-	-	-
Net Income	-29	-64	-72	-27	-60	-50
Net Profit Margin	-2461.51%	-2916.15%	-7609.81%	-1848.37%	-3225.04%	-1238.52%

Insight Molecular Diagnostics Inc. Quarterly Cash Flow

All numbers in Millions USD

	Sep 2023	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Net Income	-6	-9	-4	-13	-33	-6	-9	-10	-22
Operating Cash Flow	-2	-3	-5	-5	-5	-5	-6	-4	-5
Investing Cash Flow	-1	0	0	0	0	0	0	-1	-1
Financing Cash Flow	0	0	9	0	10	28	0	0	0
Change in Cash	-3	-3	3	-5	5	22	-6	-5	-7

Insight Molecular Diagnostics Inc. Annual Cash Flow

All numbers in Millions USD

	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024	Dec 2025
Net Income	-19	-15	-22	-29	-64	-72	-27	-60	-50
Operating Cash Flow	-13	-11	-19	-25	-35	-45	-23	-20	-22
Investing Cash Flow	0	0	-12	-11	-13	-4	0	0	-3
Financing Cash Flow	9	12	47	22	78	35	12	20	28
Change in Cash	-2	0	15	-14	28	-14	-12	0	3

Insights on Insight Molecular Diagnostics Inc.

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

POSITIVE IMPACT
Best in 1 Year
In the last 1 year, IMDX has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Price Rise
In the last 1 month, IMDX stock has moved up by 38.0%
POSITIVE IMPACT
Best in 3 Years
In the last 3 years, IMDX has outperformed top 5 stocks with highest market-cap in its industry
POSITIVE IMPACT
Revenue Rich
Revenue is up for the last 2 quarters, 260.0K → 1.13M (in $), with an average increase of 77.2% per quarter
NEGATIVE IMPACT
Profit Down
Netprofit is down for the last 4 quarters, -6.67M → -22.95M (in $), with an average decrease of 56.3% per quarter

About Insight Molecular Diagnostics Inc.

Insight Molecular Diagnostics Inc. operates as a precision diagnostics company in the United States and internationally. The company develops and commercializes laboratory developed tests, kitted research use only tests, and kitted clinical tests. It is developing DetermaCNI, a blood-based monitoring tool that detects progression early after one cycle cancer treatment; and DetermaIO, a gene expression test that assesses the tumor microenvironment to predict response to immunotherapies. The company also offers GraftAssureCore test, a blood test designed to measure dd-cfDNA using a novel PCR-based measurement platform, for potential patient registrants; GraftAssureIQ, a transplant monitoring assay to measure the donor-derived cell-free DNA; and GraftAssureDx, a decentralized transplant monitoring levels of donor-derived cell-free DNA in plasma following kidney transplantation to aid in the assessment of the probability of allograft rejection at the time of testing in conjunction with standard clinical assessments. In addition, it provides testing services for biomarker discovery, assay design and development, clinical trial support, and various biomarker tests. The company has a collaboration agreement with Bio-Rad Laboratories, Inc. for the development and commercialization of research use only and in vitro diagnostics kitted transplant products using Bio-Rad's ddPCR instruments and reagents. The company was formerly known as OncoCyte Corporation and changed its name to Insight Molecular Diagnostics Inc. in June 2025. Insight Molecular Diagnostics Inc. was incorporated in 2009 and is based in Nashville, Tennessee.

Organisation	Insight Molecular Diagnostics Inc.
Headquarters	2 International Plaza Dr., Nashville, TN, United States, 37217
Industry	Diagnostics & Research
CEO	Mr. Joshua Riggs
E-voting on shares	Click here to vote

Key Management of Insight Molecular Diagnostics Inc.

Name	Title
Ms. Andrea Susan James	Chief Financial Officer
Mr. James Liu	VP of Accounting, Treasurer, Controller & Principal Accounting Officer
Mr. Yuh-Min Chiang Ph.D.	Chief Technology Officer
Dr. Paul R. Billings FACP, M.D., Ph.D.	Consulting Chief Medical Officer
Mr. Joshua Riggs	President, CEO & Director
Dr. Ekkehard Schutz M.D., Ph.D.	Chief Science Officer
Mr. Peter Hong	VP, General Counsel & Secretary
Mr. Steven Tahmooressi	Vice President of Marketing
Ms. Sandra O'Donald	Senior Vice President of Business Operations
Dr. Michael D. West Ph.D.	Scientific Advisor, Co-CEO of Biotime,Inc. & President of Biotime,Inc.

FAQs

What is Insight Molecular Diagnostics Inc. share price today?

Insight Molecular Diagnostics Inc. share price today is $5.1 as on May 14, 2026 at 8:45 am IST at the close of the market. Insight Molecular Diagnostics Inc. share today touched a day high of $5.39 and a low of $4.93.

What is the 52 week high and 52 week low for Insight Molecular Diagnostics Inc. share?

Insight Molecular Diagnostics Inc. share touched a 52 week high of $8.51 on November 12, 2025 and a 52 week low of $2.33 on August 29, 2025. Insight Molecular Diagnostics Inc. stock price today i.e. May 14, 2026 at 8:45 am IST is closed at $5.1,which is 40.07% down from its 52 week high and 118.88% up from its 52 week low.

What is Insight Molecular Diagnostics Inc.'s market capitalisation today?

Insight Molecular Diagnostics Inc. market capitalisation is $0.00T as on May 14, 2026 at 8:45 am IST.

How to invest in Insight Molecular Diagnostics Inc. Stock (IMDX) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Insight Molecular Diagnostics Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Insight Molecular Diagnostics Inc. Shares that will get you 0.2941 shares as per Insight Molecular Diagnostics Inc. share price of $5.1 per share as on May 14, 2026 at 8:45 am IST.

What is the minimum amount required to buy Insight Molecular Diagnostics Inc. Stock (IMDX) from India?

Indian investors can start investing in Insight Molecular Diagnostics Inc. (IMDX) shares with as little as ₹95.705 or $1 (as of May 14, 2026 at 2:46 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹957.05 in Insight Molecular Diagnostics Inc. stock (as per the Rupee-Dollar exchange rate as on May 14, 2026 at 2:46 pm IST). Based on Insight Molecular Diagnostics Inc. share’s latest price of $5.1 as on May 14, 2026 at 8:45 am IST, you will get 1.9608 shares of Insight Molecular Diagnostics Inc.. Learn more about fractional shares .